# A Study of LY03005 vs Pristiq

> **NCT03733574** · PHASE1 · COMPLETED · sponsor: **Luye Pharma Group Ltd.** · enrollment: 56 (actual)

## Conditions studied

- Major Depressive Disorder

## Interventions

- **DRUG:** LY03005
- **DRUG:** Pristiq

## Key facts

- **NCT ID:** NCT03733574
- **Lead sponsor:** Luye Pharma Group Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2018-06-19
- **Primary completion:** 2018-07-17
- **Final completion:** 2018-07-26
- **Target enrollment:** 56 (ACTUAL)
- **Last updated:** 2018-11-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03733574

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03733574, "A Study of LY03005 vs Pristiq". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT03733574. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*